Markets

Nasdaq Dips Amidst Rise in US Crude Inventories; Key Pharma & Tech Stocks in Focus

Published February 28, 2024

U.S. stock markets witnessed a downturn in the recent trading session, with the tech-heavy Nasdaq Composite index shedding around 50 points. Market participants responded to a variety of economic indicators and corporate news, leading to mixed sentiments. The Dow Jones Industrial Average marginally declined by 0.19% to stand at 38,899.92, and the larger S&P 500 index also experienced a slight retreat, slipping 0.11% to reach 5,072.67. In contrast, shares within the real estate sector bucked the trend, gaining 1.1% on the day.

Energy Sector Movement

The energy sector drew significant attention as U.S. crude stockpiles showcased a sizeable increase of 4.2 million barrels. This rise in crude inventories often signals a shift in supply-and-demand dynamics, potentially affecting energy prices and related stocks.

Spotlight on Pharma and Tech Stocks

A selection of pharmaceutical and tech stocks came under the spotlight amidst the market movements. Adial Pharmaceuticals ADIL, headquartered in Charlottesville, Virginia, continues its clinical-stage developments aimed at addiction and related disorders. Meanwhile, Integral Ad Science Holding LLC IAS, a digital advertising verification firm with a global presence, is stationed in New York and remains a key player in the tech-advertising domain. Other notable stocks include vTv Therapeutics Inc. VTVT, focusing on oral small molecule drug development; Inogen, Inc. INGN, which markets portable oxygen concentrators; and various other players that are significant to their sectors.

Nasdaq, Dow, S&P